Case Number:

IPR2021-00816

Case Type:

IPR

Status:

Trial Instituted

Petitioner:

Regeneron Pharmaceuticals, Inc.

Patent Owner:

Novartis Pharma AG

Tech Center:

3700

1. Filed: April 16, 2021 00:00

   Coverage

   1. January 25, 2023

      Regeneron Gets Novartis Syringe Patent Axed At PTAB

      The Patent Trial and Appeal Board has found that more than two dozen claims in a Novartis pre-filled eye injection syringe patent weren't patentable, handing Regeneron a win in a larger legal fight between the parties.

   2 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login